$PHR

Phreesia Announces Second Quarter Fiscal 2027 Results

Phreesia, Inc. (PHR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Phreesia Announces Second Quarter Fiscal 2027 Results ALL-REMOTE COMPANY/WILMINGTON, Del., September 2, 2026 – Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal second quarter ended July 31, 2026. “Phreesia deli

Original reporting
Published Sep 2, 2026, 8:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 2, 2026, 8:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$PHR
Neutral
medium confidence
Mentioned
$PHR
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$PHRNeutralLow
01

Why it matters

The reaffirmed guidance and improved cash position may sustain current investor sentiment, with limited catalyst for a sharp move.

02

Market read

Primary company news with fresh earnings data; modest relevance for traders focused on small‑cap healthcare tech.

03

What to watch

Restructuring charges and debt reduction could improve long-term cash generation.

Relevance 7/10Novelty 7/10Timing: post-market Sep 2 2026

Background

Phreesia filed an SEC Form 8‑K announcing its Q2 FY2027 financial results and reaffirming its FY2027 revenue and Adjusted EBITDA guidance.

Company-level read

Ticker impact

$PHRNeutralMedium confidence
Context

Phreesia reported Q2 FY2027 results with revenue up 10% YoY, net income $1.9M and reaffirmed FY2027 revenue and Adjusted EBITDA outlook.

Expected impact

modest upside or stability

Evidence & confidence

Positive earnings surprise and solid cash flow reinforce valuation, but no new guidance change limits upside.

Market effects

Healthcare services software may see modest confidence boost from Phreesia's performance.

U.S. small-cap healthcare tech sector could see slight positive pressure.

Limited, primarily U.S. investors.

Counterpoint

Despite earnings beat, the reaffirmed outlook suggests limited growth upside.

Key entities

  • Phreesia, Inc.

    Healthcare services software provider.

Related articles

$PHRMed

Phreesia’s (PHR) Profit Turnaround Meets A Cash-Strapped Client Base

Phreesia (PHR) reported Q2 2027 revenue of $129.5M and adjusted EBITDA of $32.9M, marking five straight quarters of positive net income. Revenue grew 10% YoY, with client count and revenue per client also increasing. The company reduced debt by $23M and credited AI for operational efficiencies. However, management warned of increased unpredictability in network solutions revenue due to financial strain on healthcare providers. Phreesia reaffirmed its full-year revenue and EBITDA guidance.

$PHRHighAI 8/10

Phreesia (PHR) Q2 2027 Earnings Call Transcript

Phreesia (PHR) reported Q2 2027 revenue of $129.5M, up 10% YoY, with adjusted EBITDA of $32.9M and net income of $1.9M. AHSCs grew 6% to 4,744. Full-year guidance: revenue $510M-$520M, adjusted EBITDA $125M-$135M. Management noted variability in revenue forecasting and economic pressures on healthcare providers.

$PHRMed

Why Phreesia Stock Got Knocked Down Today

Phreesia (PHR) stock fell 7% Tuesday due to bearish sentiment after Q2 earnings and a downgrade by Raymond James analyst John Ransom. Ransom cited declining organic revenue growth and AI spending pressures. Despite a 10% revenue increase, concerns remain about future performance and market constraints.

$PHRMed

Why Phreesia Stock Tumbled Today

Phreesia (PHR) shares fell 6.33% after reporting Q2 2027 revenue of $129.5M, up 10% YoY, and GAAP net income of $1.9M. While revenue beat estimates, earnings per share missed expectations. The company maintained full-year guidance and highlighted recent product launches.